128 related articles for article (PubMed ID: 12532967)
1. Thrombolysis and hemorrhagic transformation.
De Keyser J
Stroke; 2002 Mar; 33(3):724. PubMed ID: 12532967
[No Abstract] [Full Text] [Related]
2. Focal fluid-attenuated inversion recovery hyperintensity within acute diffusion-weighted imaging lesions is associated with symptomatic intracerebral hemorrhage after thrombolysis.
Cho AH; Kim JS; Kim SJ; Yun SC; Choi CG; Kim HR; Kwon SU; Lee DH; Kim EK; Suh DC; Kang DW
Stroke; 2008 Dec; 39(12):3424-6. PubMed ID: 18772449
[TBL] [Abstract][Full Text] [Related]
3. [Thrombolytic agents, urokinase, tissue-type plasminogen activator and pro-urokinase--their routes of administration and dosage: comparison between intracoronary thrombolysis and intravenous coronary thrombolysis].
Motomiya T
Nihon Rinsho; 2003 Apr; 61 Suppl 4():441-5. PubMed ID: 12735012
[No Abstract] [Full Text] [Related]
4. Adding to the effectiveness of intravenous tissue plasminogen activator for treating acute stroke.
Grotta JC
Circulation; 2003 Jun; 107(22):2769-70. PubMed ID: 12796412
[No Abstract] [Full Text] [Related]
5. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
6. Early disruption of the blood-brain barrier after thrombolytic therapy predicts hemorrhage in patients with acute stroke.
Kastrup A; Gröschel K; Ringer TM; Redecker C; Cordesmeyer R; Witte OW; Terborg C
Stroke; 2008 Aug; 39(8):2385-7. PubMed ID: 18556588
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol measured before stroke thrombolysis is not associated with tissue plasminogen activator-related hemorrhagic transformation.
Montaner J
Stroke; 2008 Jan; 39(1):e6. PubMed ID: 18048844
[No Abstract] [Full Text] [Related]
8. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
9. Local intra-arterial thrombolysis with urokinase for acute ischemic stroke before and after the approval of intravenous tissue plasminogen activator treatment in Taiwan.
Yang FC; Lin CC; Hsueh CJ; Lee JT; Hsu CH; Lee KW; Peng GS
Ann Vasc Surg; 2010 Nov; 24(8):1117-24. PubMed ID: 21035704
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT.
Ueda T; Hatakeyama T; Kumon Y; Sakaki S; Uraoka T
Stroke; 1994 Feb; 25(2):298-303. PubMed ID: 8303735
[TBL] [Abstract][Full Text] [Related]
11. Intraarterial thrombolysis and stent placement for acute basilar artery occlusion.
Yu YY; Niu L; Gao L; Zhao ZW; Deng JP; Qu YZ; Jiao DR; Yang JQ; Gao GD
J Vasc Interv Radiol; 2010 Sep; 21(9):1359-63. PubMed ID: 20688533
[TBL] [Abstract][Full Text] [Related]
12. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
[TBL] [Abstract][Full Text] [Related]
13. [Thrombolytic (fibrinolytic) agents for treatment of ischemic heart disease].
Nagao K; Kanmatsuse K
Nihon Rinsho; 2003 Apr; 61 Suppl 4():641-6. PubMed ID: 12735044
[No Abstract] [Full Text] [Related]
14. Hemorrhagic complications of thrombolytic therapy.
Vujković Z; Racić D; Miljković S; Dajić V
Med Pregl; 2012; 65(1-2):9-12. PubMed ID: 22452232
[TBL] [Abstract][Full Text] [Related]
15. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
16. Risks and benefits of thrombolysis in the elderly.
Asdaghi N; Butcher KS; Hill MD
Int J Stroke; 2012 Feb; 7(2):142-9. PubMed ID: 22264367
[TBL] [Abstract][Full Text] [Related]
17. Intra-arterial thrombolysis.
American Society of Interventional and Therapeutic Neuroradiology
AJNR Am J Neuroradiol; 2001 Sep; 22(8 Suppl):S18-21. PubMed ID: 11686069
[No Abstract] [Full Text] [Related]
18. Changes in coagulation and fibrinolytic system after local intra-arterial thrombolysis for acute ischemic stroke.
Ueda T; Hatakeyama T; Sakaki S; Ohta S; Kumon Y; Uraoka T
Neurol Med Chir (Tokyo); 1995 Mar; 35(3):136-43. PubMed ID: 7770106
[TBL] [Abstract][Full Text] [Related]
19. Fibrinogen decrease after intravenous thrombolysis in ischemic stroke patients is a risk factor for intracerebral hemorrhage.
Vandelli L; Marietta M; Gambini M; Cavazzuti M; Trenti T; Cenci MA; Casoni F; Bigliardi G; Pentore R; Nichelli P; Zini A
J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):394-400. PubMed ID: 25497721
[TBL] [Abstract][Full Text] [Related]
20. Does dementia increase risk of thrombolysis?: a case-control study.
Alshekhlee A; Li CC; Chuang SY; Vora N; Edgell RC; Kitchener JM; Kale SP; Feen E; Piriyawat P; Callison RC; Cruz-Flores S
Neurology; 2011 May; 76(18):1575-80. PubMed ID: 21451151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
